Lilly and Inctye will be seeking a label update for the JAK inhibitor for its use in paediatric patients with alopecia areata ...

Dupixent’s Q3 sales increased by 26.2%, breaking through the €4bn ceiling for the first time in a single quarter.

GSK has received US Food and Drug Administration (FDA) approval for Blenrep to be used along with BVd for multiple myeloma.

The MHRA's raid follows an uptick in the trade of illegal GLP-1RA drugs used for obesity and type 2 diabetes amid shortages ...

EUROAPI has announced Med4Cure, an initiative within the Health Important Project of Common European Interest (IPCEI) ...